[Medical therapy of obliterating arteriosclerosis of the lower extremities].
D000925:Anticoagulants / Q000627:therapeutic use*; D001161:Arteriosclerosis; D001162:Arteriosclerosis Obliterans / Q000628:therapy*; D004032:Diet; D006801:Humans; D035002:Lower Extremity; D011343:Procaine / Q000627:therapeutic use*; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000925:Anticoagulants; D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D011343:Procaine
ANTICOAGULANTS/therapeutic use; ARTERIOSCLEROSIS OBLITERANS/therapy; DIETS; PROCAINE/therapeutic use; VASOMOTOR DRUGS/therapeutic use
Tratamiento medico de la arteriosclerosis obliterante de los miembros inferiores.